Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on Oct 21, 2024 2:49pm
67 Views
Post# 36275278

RE:MPL to be sold.

RE:MPL to be sold.
alleyesonme wrote: Keith stepping over to the board in order to transition MPL into the larger entity purchasing the Corp. (IMO speculation)..  the recent PR didn't mention who will be taking over as president/wheather Pidduck will assume the role/ or if a search is underway...this was by no means poor performance on Keith's end otherwise he would never been given a seat on the board...pre q run up typically occurs week prior, never three weeks...something's up and the rumour mill is turning on bay st...majority of shares are being bought up by institutional investors...(anonymous, a cover only offered to institutions)....should be an interesting couple of months...Keith did say he would be busy preparing for the epidiolex launch in the US. Perhaps a deal is being negotiated before this hard date/partnership details are released...MPL is the only Corp other than Jazz with the certs/and ability for large scale manufacturing today (to my knowledge) for a prompt and swift entrance into the generic epidolex arena....


Sold at what valuation?  The current or the possible?  No way this business sells at the current and no way of knowing what the possible is until the big catalyst shoe drops and thus nobody votes in favour until then.  Now if a big announcement comes and in combo an offer is made on the back of that then fine.  But I for one wouldn't mind letting Pidduck take the Ferrari out of the garage for a little while before selling it off unless the price is just too juicy to ignore.  And a juicy price doesn't have a zero to start it.
<< Previous
Bullboard Posts
Next >>